Publications - Discoveries and Innovations from Incucyte

0
Total number of publications
0
Number of publications this year
Displaying 327 results out of a total of 2729 publications.

Filter publications:

Search publications:

Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
Sootichote, R;Thuwajit, P;Singsuksawat, E;Warnnissorn, M;Yenchitsomanus, PT;Ithimakin, S;Chantharasamee, J;Thuwajit, C;
BMC Cancer, BMC Cancer, 18(1):231, 2018
View publication
Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity
Karlsson, H;Frykns, M;Strese, S;Gullbo, J;Westman, G;Bremberg, U;Sjblom, T;Pandzic, T;Larsson, R;Nygren, P;
Oncotarget, Oncotarget, 8(18):30217-30234, 2018
View publication
Synergy of WEE1 and mTOR inhibition in mutant KRAS-driven lung cancers
Hai, J;Liu, S;Bufe, L;Do, K;Chen, T;Wang, X;Ng, C;Li, S;Tsao, MS;Shapiro, GI;Wong, KK;
Clin. Cancer Res., Clin. Cancer Res., ():, 2017
View publication
TGF-β: an emerging player in drug resistance
Brunen, D, Willems, SM, Kellner, U, Midgley, R, Simon, I, Bernards, R,
Cell Cycle, 12(18), 2960-8, 2013
View publication
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
Hoshi, H;Hiyama, G;Ishikawa, K;Inageda, K;Fujimoto, J;Wakamatsu, A;Togashi, T;Kawamura, Y;Takahashi, N;Higa, A;Goshima, N;Semba, K;Watanabe, S;Takagi, M;
Oncol. Rep., Oncol. Rep, 2016
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
Ferguson, J;Smith, M;Zudaire, I;Wellbrock, C;Arozarena, I;
Oncotarget, Oncotarget, 8(20):32946-32959, 42871, 2018
View publication
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
R_s_nen, M;Degerman, J;Nissinen, TA;Miinalainen, I;Kerkel_d, R;Siltanen, A;Backman, JT;Mervaala, E;Hulmi, JJ;Kivel_, R;Alitalo, K;
Proc. Natl. Acad. Sci. U.S.A., Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13144-13149. Epub 2016 Oct 31., 2017
The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells
Lotte M.E., Berghauser Pont, et al
Genes & Cancer, 5, 445-459, 2014
View publication
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
Kuruvilla, SP;Tiruchinapally, G;Crouch, AC;ElSayed, MEH;Greve, JM;
PLoS ONE, PLoS ONE, 12(8):e0181944, 2017
View publication
Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123+ Cancer
Bayle, JH;Duong, MT;Lu, A;Morschl, E;Collinson-Pautz, MR;Sharp, KL;Szymanski, S;Brandt, ME;Slawin, KM;Toler, S;Yvon, E;Foster, A;Spencer, DM;
Blood, Blood, 130(S1):3184, 2018
View publication
1 2 3 4 5 6 7 8 9 10 11 12 ...
No file selected
0%
Stay up-to-date with what's happening at Essen BioScience

© 2020 Essen BioScience

Privacy Policy